Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice

Journal of Infectious Diseases

Volumn 198, Issue 4, 2008, Pages 571-575

  Arrecubieta, Carlos ^a   Matsunaga, Iwao ^a   Asai, Tomohiro ^a,b   Naka, Yoshifumi ^a   Deng, Mario C ^a   Lowy, Franklin D ^a  

^a Columbia University ^*  (United States)

^b NEW TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CLUMPING FACTOR A; CLUMPING FACTOR A ANTIBODY; FIBRONECTIN BINDING PROTEIN A; FIBRONECTIN BINDING PROTEIN A ANTIBODY; FIBRONECTIN BINDING PROTEIN B; MONOCLONAL ANTIBODY; POLYURETHAN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; INFECTION PREVENTION; MONOTHERAPY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEIN DOMAIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; VACCINATION;

ADHESINS, BACTERIAL; ANIMALS; AORTA; BACTERIAL VACCINES; COAGULASE; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; IMMUNIZATION, PASSIVE; MICE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VACCINATION; VIRULENCE;

EID: 48749086405     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/590210     Document Type: Article

References (15)

1. Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004; 23:1359-65.
2. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis 2006; 6:426-37.
3. Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg 1999; 118:404-13.
4. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48:585-617.
5. Arrecubieta C, Asai T, Bayern M, et al. The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis 2006; 193:1109-19.
6. Bremell T, Lange S, Svensson L, et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990; 33:1739-44.
7. 2+-dependent inhibitory site. J Biol Chem 1998; 273:6821-9.
8. Roche FM, Downer R, Keane F, Speziale P, Park PW, Foster TJ. The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem 2004; 279:38433-40.
9. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184:1572-80.
10. Que YA, Haefliger JA, Piroth L, et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005; 201:1627-35.
11. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63:4738-43.
12. Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog 1993; 15:227-36.
13. Mamo W, Jonsson P, Flock JI, et al. Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine 1994; 12:988-92.
14. Shinefield HR, Black S. Prospects for active and passive immunization against Staphylococcus aureus. Pediatr Infect Dis J 2006; 25:167-8.
15. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A 2006; 103:16942-7.